Here are our favorite stories we wrote in 2024

’Tis the season…for patting ourselves on the back a little bit.

We’re proud of the work we’ve done and had great conversations with sources, so we’re reflecting on some of what we published in 2024. Here are a few of our favorite stories we wrote this year.

We can’t wait to see what next year holds in store for Healthcare Brew!

What the Chevron ruling means for the healthcare industry

I really enjoyed reporting on and writing this piece because the topic is something that has such wide implications for not just healthcare but every industry in the US. The ripple effects of the Chevron doctrine being overturned will likely be felt for years, and this story that I was able to write with Cassie is a grounding piece on what the decision was and how it could change healthcare in the future.—MA

Abortion protections are on the ballot in 10 states this November. Here’s what’s at stake

I came to Healthcare Brew in July after three years at the Orlando Sentinel, where I covered abortion a lot. It was gratifying to finally report on it at the national level for this article in which I got to add nuance to little-known ballot issues and talk to sources ranging from Planned Parenthood executives to small, independent abortion clinics.—CC

With bans in more than 20 states, here’s where trans healthcare access currently stands

Trans healthcare has been highly controversial in recent years, with bans popping up around the country to restrict access to gender-affirming care that can positively impact patient health. I was proud to report on where trans healthcare currently stands in the US and give readers clear, researched information about an issue around which there’s a lot of misinformation. One of the reasons I love journalism is because it empowers people through truth and brings awareness to how people on the ground are affected by legislation.—CM

Are we entering a neurotechnology renaissance in healthcare?

Hollywood loves a reboot, and so does neurology. A trend that caught my eye is a revival of a rather old-school tech approach to treating mental health conditions that don’t always respond well to new drugs, and it’s yielded some really promising results so far. It was really interesting to trace how a convergence of innovations made “neuromodulation 2.0” (as one CEO called it) happen.—CH

Climate change-fueled extreme heat is worsening. Experts worry about the effect on patients

This September, I attended the first Climate Week NYC that featured dedicated healthcare panels. One of the recurring themes of the sessions I sat in on was how extreme heat is affecting patients—leading to increased cases of illnesses like asthma, kidney issues, and high blood pressure—as well as what hospitals are doing in response to improve care. I also spoke with AstraZeneca’s VP of global sustainability about how extreme heat is affecting pharma. It’s an important topic to stay keyed in to, and I’m excited to see how we develop more coverage around it.—NO